Related references
Note: Only part of the references are listed.Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment
Tanvi Khera et al.
JOURNAL OF VIRAL HEPATITIS (2022)
Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8+ T-Cell Function
Cody Orr et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Characterization of a Novel Hepatitis C Virus Genotype Subtype 1 from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment
Martin S. Pedersen et al.
MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2021)
Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C
Lone W. Madsen et al.
LIVER INTERNATIONAL (2021)
The Role of PD-1 in Acute and Chronic Infection
Jil M. Jubel et al.
FRONTIERS IN IMMUNOLOGY (2020)
Adaptive Immune Response against Hepatitis C Virus
Janine Kemming et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C
Sylwia Osuch et al.
SCIENTIFIC REPORTS (2020)
Peripheral PD-1+ T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
Sara Romani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Barbara Rehermann et al.
GASTROENTEROLOGY (2019)
Baseline Intrahepatic and Peripheral Innate Immunity Are Associated With Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy
Hawwa Alao et al.
HEPATOLOGY (2018)
Restoration of natural killer cell activity by interferon-free direct-acting antiviral combination therapy in chronic hepatitis C patients
Ikuo Nakamura et al.
HEPATOLOGY RESEARCH (2018)
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients
Benjamin Maasoumy et al.
LIVER INTERNATIONAL (2018)
Short-Duration Treatment With Elbasvir/Grazoprevir and Sofosbuvir for Hepatitis C: A Randomized Trial
Eric Lawitz et al.
HEPATOLOGY (2017)
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
Dominik Wieland et al.
NATURE COMMUNICATIONS (2017)
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12
Christoph R. Werner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function
Elisavet Serti et al.
GASTROENTEROLOGY (2015)
Predictive factors associated with hepatitis C antiviral therapy response
Lourianne Nascimento Cavalcante et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Restoration of HCV-specific CD8+T cell function by interferon-free therapy
Bianca Martin et al.
JOURNAL OF HEPATOLOGY (2014)
Innate and adaptive immune responses in HCV infections
Markus H. Heim et al.
JOURNAL OF HEPATOLOGY (2014)
The who's who of T-cell differentiation: Human memory T-cell subsets
Yolanda D. Mahnke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
David Gardiner et al.
PLOS ONE (2013)
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
Julian Schulze zur Wiesch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Genetics of IL28B and HCV-response to infection and treatment
C. Nelson Hayes et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Ribavirin Exerts Differential Effects on Functions of Cd4+ Th1, Th2, and Regulatory T Cell Clones in Hepatitis C
Bettina Langhans et al.
PLOS ONE (2012)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization
Nobuhiro Nakamoto et al.
GASTROENTEROLOGY (2008)
Cutting edge: Programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: Race-dependent differences
Lucy Golden-Mason et al.
JOURNAL OF IMMUNOLOGY (2008)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S. Conjeevaram et al.
GASTROENTEROLOGY (2006)
Share Paper
